Electrophysiology News and Research

RSS

Essen Instruments, Origene Technologies partner to co-develop ion channel cell lines

Essen Instruments Inc. and OriGene Technologies, Inc. today announced a strategic alliance to co-develop ion channel cell lines. Essen, based in Ann Arbor Michigan, is a leading provider of life science products and services, including ion channel discovery and safety assays. OriGene, headquartered in Rockville, Maryland, specializes in the creation and supply of gene-centric products, and has a collection of over 30,000 human full length cDNA clones.

17 Mar 2010

Japanese ablation devices market: Emerging trends that will fuel market growth

According to Millennium Research Group, the global authority on medical technology market intelligence, the recent launch of irrigated-tip catheters into the Japanese market will drive the ablation catheter market by a compound annual growth rate of approximately 15% through 2014.

10 Mar 2010

UC Davis Medical Center to implement LUMEDX Apollo interoperability solutions for cardiovascular information management

LUMEDX Corporation, a leading provider of vendor-neutral, integrated medical imaging and information systems, today announced that UC Davis Medical Center purchased LUMEDX Apollo structured reporting, analytic and interoperability solutions for their Heart and Vascular Centers. Prior to these purchases, UC Davis Medical Center used the Apollo clinical data repository solely to support cardiac registry participation.

2 Mar 2010

Study indicates GABA neurotransmitters could play a key role in major depressive disorder

The next advance in treating major depression may relate to a group of brain chemicals that are involved in virtually all our brain activity, according to a study published today in Biological Psychiatry.

2 Mar 2010

WSU Boonshoft School of Medicine and Miami Valley Hospital form new neuroscience institute

Wright State University Boonshoft School of Medicine and Miami Valley Hospital announced today the formation of the Wright State University & Premier Health Partners Neuroscience Institute to speed the transfer of research discoveries from bench to bedside, improving the diagnosis and treatment of neurological disorders such as stroke. Ohio Governor Ted Strickland and Chancellor of the Ohio Board of Regents Eric Fingerhut joined Wright State University and Miami Valley Hospital officials in making the announcement.

25 Feb 2010

Boston Scientific combines Cardiovascular Group and Cardiac Rhythm Management Group

Boston Scientific Corporation today announced a series of management changes and restructuring initiatives designed to strengthen the Company and position it for long-term success.

11 Feb 2010

Boston Scientific reports fourth quarter and full year 2009 results

Boston Scientific Corporation today announced financial results for the fourth quarter and full year ended December 31, 2009, as well as guidance for net sales and earnings per share (EPS) for the first quarter and full year 2010.

10 Feb 2010

Hospitals use new robotic catheter guidance system to treat abnormal heart rhythms

The robotic system "enhances a doctor's natural ability, and we believe it will contribute to improved procedural outcomes," said Dr. David Wilber of Loyola University Health System, a nationally known researcher in heart rhythm disorders.

10 Feb 2010

Molecular Devices brand re-launched into life sciences marketplace

Today, Molecular Devices, Inc.—now part of Danaher Corporation—re-launched the Molecular Devices brand into the life sciences marketplace. The renewed corporate brand is focused primarily on meeting customer needs and exceeding customer expectations, and includes an evolved visual identity system.

From Danaher 4 Feb 2010

St. Jude Medical to commence enrollment in IRASE AF trial

St. Jude Medical, Inc. today announced it has received an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) to begin enrollment in the IRASE AF (IRrigated Ablation System Evaluation for AF) trial, a multicenter, randomized, single-blind study evaluating the safety and efficacy of the company’s Duo 12 port open irrigated catheter ablation system for treatment of Atrial Fibrillation (AF). AF is the most common cardiac arrhythmia (abnormal heartbeat), affecting an estimated 3.3 million Americans and millions more worldwide.

4 Feb 2010

Penn Medicine experts available to offer medical insight and commentary during 2010 Winter Olympics

Experts from the University of Pennsylvania School of Medicine are available to offer expert medical insight and commentary during the 2010 Winter Olympics in Vancouver on issues ranging from the effects of performance enhancing drugs to concerns about the spread of novel H1N1, head trauma and more.

3 Feb 2010

PHI installs Infinix VF-i vascular X-ray system with12” x 12” mid-sized FPD

Increasing its ability to provide patients with the highest quality of care, Piedmont Hospital in Atlanta has installed the country’s first InfinixTM VF-i vascular X-ray system with the 12” x 12” mid-sized flat panel detector (FPD) from Toshiba America Medical Systems, Inc. The new mid-sized FPD system is equipped with Toshiba’s Next Generation Advanced Image Processing (AIP) capabilities and marks the fourth Toshiba Infinix-i system installed by Piedmont Hospital.

27 Jan 2010

Scott & White conducts DBS research for Parkinson's patients

At Scott & White Memorial Hospital, a multi-disciplinary team of neurosurgeons, neurologists, neurophysiologist, neuropsychologists and a movement disorders specialist are offering hope to some Parkinson's patients with a treatment called Deep Brain Stimulation (DBS). DBS involves placing a thin wire that carries electrical currents deep within the brain on Parkinson's patients who are no longer benefitting from medications, and have significant uncontrollable body movements called dyskinesia. Scott & White is also performing research into the effects of DBS on the non-motor symptoms of Parkinson's disease including "drenching sweats," bladder dysfunction, depression, hallucination, anxiety, and dementia as well as intestinal disorders, loss of sense of smell, and sleep disturbances.

27 Jan 2010

Fluxion Biosciences expands its IonFlux automated patch clamp system

Fluxion Biosciences announced today a product expansion for its IonFlux automated patch clamp system which includes full automation and walk-away capability.

From Fluxion Biosciences 27 Jan 2010

Air pollution is associated with increased cardiac events

Even healthy people exposed to ultrafine particulate pollution associated with traffic and fossil-fuel combustion for just two hours show changes in heart rhythm and evidence of clot formation that may herald the potential for serious cardiac events, according to research from the Environmental Protection Agency.

23 Jan 2010

Vivian and Seymour Milstein Family Heart Center to open to patients in February

Ushering in a new era in comprehensive cardiac care, the Vivian and Seymour Milstein Family Heart Center celebrated its opening today at NewYork-Presbyterian Hospital/Columbia University Medical Center.

21 Jan 2010

Sanofi-aventis U.S. brings national experts together to help aging Americans with AFib

National medical and lifestyle experts have been brought together by sanofi-aventis U.S. to help aging Americans learn to live life more fully despite a serious and increasingly prevalent heart condition – atrial fibrillation (AFib), a type of irregular heartbeat.

21 Jan 2010

New technique could bring immense benefits for patients with irregular heart rhythm

Scientists at the University of Leicester are 'painting' the colours of the heart in an innovative project that has potential to bring benefits for millions of people with irregular heart rhythm.

20 Jan 2010

Corventis' NUVANT MCT System for detecting non-lethal arrhythmias receives FDA marketing clearance

Corventis, Inc., a developer of wireless cardiovascular solutions, announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its NUVANT™ Mobile Cardiac Telemetry (MCT) System for the detection of non-lethal arrhythmias. In addition, the company announced that its Monitoring Center has been approved by the Center for Medicare & Medicaid Services (CMS) as an Independent Diagnostic Testing Facility (IDTF). Corventis has also received approval to bill for services provided to patients with Medicare and several commercial insurers, paving the way for the NUVANT MCT System to be available across the United States.

19 Jan 2010

Novel technique eliminates radiation exposure to patients and medical providers

A growing body of research continues to warn of the potential long-term effects of radiation exposure for patients and medical providers during such imaging procedures as x-rays and computed tomography (CT) scans, both of which are traditionally used with certain heart procedures.

18 Jan 2010